Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Healing & Recovery
Anti-inflammatory tripeptide derived from alpha-melanocyte stimulating hormone.
Peptide B
Healing & Recovery
Broad neuropeptide with anti-inflammatory, immunomodulatory, and vasodilatory activity.
Typical vial
5 mg
Typical dose
200-500 mcg
Half-life
~15-30 minutes (short half-life typical of small peptides)
FDA status
Not FDA approved for human use.
Typical vial
5 mg
Typical dose
50-200 (intranasal) mcg
Half-life
~2 minutes (plasma); longer functional duration via tissue distribution
FDA status
Not FDA approved as therapeutic. VIP analog aviptadil receiv…
KPV effects
VIP (Vasoactive Intestinal Peptide) effects
KPV side effects
VIP (Vasoactive Intestinal Peptide) side effects
KPV dosing ranges
Gut inflammation support
200-500 mcg · Once or twice daily (oral or SubQ) · 4-8 weeks
Systemic anti-inflammatory
200-500 mcg · Once daily (SubQ) · 4-6 weeks
VIP (Vasoactive Intestinal Peptide) dosing ranges
Intranasal CIRS protocol (off-label)
50 mcg · 4 sprays daily · Per Shoemaker protocol; months to years for full restoration
Research / immunomodulation
Variable per protocol · Per protocol · Per protocol
KPV: Anti-inflammatory tripeptide derived from alpha-melanocyte stimulating hormone. Typical dose 200-500 mcg. VIP (Vasoactive Intestinal Peptide): Broad neuropeptide with anti-inflammatory, immunomodulatory, and vasodilatory activity. Typical dose 50-200 (intranasal) mcg. Both fall under the Healing & Recovery category.
Stacking KPV with VIP (Vasoactive Intestinal Peptide) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
KPV is typically dosed: Once or twice daily (oral or SubQ) for Gut inflammation support; Once daily (SubQ) for Systemic anti-inflammatory. VIP (Vasoactive Intestinal Peptide) is typically dosed: 4 sprays daily for Intranasal CIRS protocol (off-label); Per protocol for Research / immunomodulation.
KPV: Not FDA approved for human use. VIP (Vasoactive Intestinal Peptide): Not FDA approved as therapeutic. VIP analog aviptadil received Emergency Use Authorization consideration for COVID-19 ARDS but not full approval.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free